Zydus Wellness Limited CC-May26.pdf · 2026-05-18
Yes. So my question is related to the RiteBite segment. As we were saying, in the previous quarter also and, from the last three quarters that we are seeing approximately double of what growth rate before acquisition RiteBite was seeing. So for the whole year, we have seen that kind of growth of 50%, so INR244 crores or something. But what is an expectation going forward as we are doing innovation in this segment? Do we feel that we are going to get into major adjacencies in this RiteBite segment? Or are we going to continue on the protein bar and the Ready-to-Drink segment only?
Perfect. On the seasonal portfolio, as you rightly mentioned that since this last year wasn't great for the seasonal portfolio. And since the summer is harsh this time, it has started, might be little late, but is harsh. So what I just wanted to understand when we say the category. So when we see the numbers, the category is degrowing, but we say that we are going to have a double-digit growth. So most probably we are going to take market share. In Glucon-D or Complan , Complan is a degrowing segment. So where are you going to get growth from, in the sense that the category is degrowing, but you're saying that you're going to grow in double digit on a longer-term basis? So just wanted to know the thesis behind that.